Testimonials From Health Economics for Non-Health-Economists
The programme is very well balanced in terms of topics, theory and examples and organisation of the course. The lecturer is brilliant. Thanks!
NovartisMariya Vladova, Innovative Market Access, Value and Data Insights Manager - Bulgaria - June 2022 (face-to-face course)
Very comprehensive, yet practical and quick, introductory course into HEOR. Lieven is a knowledgeable, clear talker, enthusiastic about his field. Mixed audience in level of experience and companies, very nice. Thanks for everything, I enjoyed the training - it was very useful, nice and well organised.
AstellasOlga Wedemeier, Sr. Medical Director BeNeLux - The Netherlands - June 2022 (face-to-face course)
Lieven Annemans and his expertise made this a great course. I highly valued the examples from real life, the very clear theory and presentation and also the exercises. I really recommend this course.
Daiichi SankyoPinar Özeken, Director Pricing & Value & Access Specialty Business Division Daiichi Sankyo Europe - Germany - June 2022 (face-to-face course)
This training is a must for non-HE who want to develop further in HE.
GlaxoSmithKlineRaymond Kienhuis, Field Market Access Manager - The Netherlands - June 2022 (face-to-face course)
This training is a MUST for any professional new to the pharma sector. The big picture and key principles of Health Economics are presented in a comprehensive manner and are accompanied with many actionable insights.
JanssenJonathan Dicker, Manager Global Pricing Analytics - Belgium - December 2021 (face-to-face course)
The course was very insightful. The expert knowledge of Lieven and his great way of disseminating his knowledge made the course very valuable. Although the course was mainly discussing examples from the pharmaceutical industry, the methods and general application of HE were easily understandable and could easily be "transitioned" to the medical technology industry as well. Anyone can easily follow the course and really gain sufficient knowledge and insight in HE evaluations, market access methodologies that can help companies improve their chances in achieving greater market access, and efficient ways to approach information and data gathering for amplifying the value of new technologies. Highly recommended!
MedTech EuropePanagiotis Kokkinos, Digital Health Access Officer - Belgium - December 2021 (face-to-face course)
Lieven really inspired me during this 2-day course.
JanssenRudy Taels, Business Intelligence Manager Neurosciences Benelux - The Netherlands - December 2021 (face-to-face course)
A very complete, very insightful course that is useful to apply in a company setting. For me the online experience was excellent, no improvements needed. Thanks a lot to Lieven and to CELforPharma!
RocheChristel Van-Weert, Head of Reputation Management - Belgium - June 2021 (live online course)
A very clear & concise course that was perfectly fitted to my level of understanding. Not too simple, not too advanced, with a nice balance of lectures and exercises. There was some really fun and constructive interaction within the group and it was interesting to hear from other countries' perspectives during group discussions. Many thanks to all involved!
SanofiErland Marstein, Franchise Lead Immunology Norway - Norway - June 2021 (live online course)
This was a great opportunity to brush up on some skills and to interact with a knowledge expert in the field.
NovartisAlbert Hsu, Director, Global Market Access - Switzerland - March 2021 (live online course)
The HE course was absolutely excellent, pitched at the right level and helped me understand (and demystify!) this topic! There is an excellent balance between theory and practices with tangible real-life examples/illustrations. The trainer was excellent, showed huge expertise and was engaging! I strongly recommend this course!
Vertex PharmaceuticalsCeline Ladure, International Marketing Director - United Kingdom - March 2021 (live online course)
I highly enjoyed the course. In only 2 days you get a great overview of HE and a couple of very pragmatic tools for how to think about issues in the field, as a layman. The theory becomes very tangible and applicable in everyday life.
PfizerClaire-Marie Rothlübbers, Sr Manager Market Access - Switzerland - March 2021 (live online course)
I just loved it! Great training, great teacher, perfectly managed by CELforPharma. It was a perfect mix of theory, group exercises, individual exercises, and discussions. These two days will provide you with all the needed tools to understand and challenge health economics models.
AbbVieJade Royers, Market Access Value Proposition Manager - Belgium - March 2021 (live online course)
I have left the course with a lot more understanding of health economic evaluations, and the complexity in coming up with the data to inform payers and pharma companies in making decisions regarding treatment options. I plan to also follow the HTA course to see what the difference is and explore the possibility of specialising in this field.
Novo NordiskMonica Mirigo, Quality Assurance Specialist for Middle Africa - Kenya - March 2021 (live online course)
Very rich and intense experience taking this course. Would highly recommend to anyone looking to sharpen their knowledge and Health Economics understanding and its application in Pharma.
Novo NordiskPeter Mburu, Medical Advisor - Southern Africa - Kenya - March 2021 (live online course)
Excellent course that provides a strong foundation of understanding, particularly for those not leading on HEE's.
AstraZenecaToby Sloman, Marketing Manager - United Kingdom - December 2020 (live online course)
Health Economics for Non-Health-Economists was a great opportunity to learn the basics in this field from an expert and feel comfortable to take part in future health economical discussions.
Jazz PharmaceuticalsMartina Schmidt, Medical Science Liaison - France - December 2020 (live online course)
As a Marketer, I now understand why my Access colleagues push for robust HE data early on, and how important it is to ensure consistency across the whole Brand Strategy. It is also important to make the LCM discussions more grounded into the reality of Ex-US countries reimbursement systems, especially when decisions on data generations are made at the global level.
Emergent BiosolutionsAurelie Lelong, EU Marketing Director - Switzerland - December 2020 (live online course)
A really informative, practical and fun experience!
ConvaTecLorraine Ralph, Clinical Evidence and Publications Manager - United Kingdom - December 2020 (live online course)
Excellent course with great lecturer and excellent organisation.
AmgenCaroline Van den Eede, Scientific Communications - Belgium - October 2020 (face-to-face course)
I experienced a lovely 2-day course in Pharmaco-Economics where key-principles and insights are very clearly explained. Time perspective wise you receive a lot of value, from the first till the last minute. Lieven Annemans is a great teacher and he’s capable of creating a very positive atmosphere during the course. As a 100% Non-Economist I’m able now to really understand much better the dynamics of this crucial step in the market.
GE HealthcareStijn Vanvlasselaer, Sales Manager - Belgium - October 2020 (face-to-face course)
Attend this course and learn to think as a health economist! Very good presenter, clear slides, clear examples, interactive with the audience, top!
PfizerLaurens De Backer, Brand and Channel Manager - Belgium - October 2020 (face-to-face course)
After this course I am eager to bring this knowledge into practice.
AmgenEvi Denolet, Sr. Medical Advisor - Belgium - October 2020 (face-to-face course)
Great course, great presenter. Really informative, useful introduction into some of the technical elements of health economics.
PfizerJack Kowalik, HTA Manager - United Kingdom - December 2019 (face-to-face course)
A great valuable course. The importance of Health Economics is clearly explained.
SantheraJur Van der Wild, Market Access Manager EU - The Netherlands - December 2019 (face-to-face course)
Very immersive course. Lieven is an excellent presenter who can make complex things easy to understand and with some good humor also!
NovartisMark Kerins, Key Account Manager - Ireland - December 2019 (face-to-face course)
An excellent course for those who start the journey of Market Access or dealing with HTAs. An outstanding professor with great practical experience made the training easier + sensible.
AbbottSameh Essa, Market Access & Strategic Alliances Manager Middle East & Africa - United Arab Emirates - December 2019 (face-to-face course)
Thank you for delivering this excellent course. My attendance here will directly impact my ability to support the reimbursement process in my markets. And it was fun, highly engaging and a great networking opportunity!
SantheraElodie Denjean, Country Manager, UK & Ireland - United Kingdom - December 2019 (face-to-face course)
The course was a very positive learning experience that largely met my original expectations. I would recommend the course to anyone who wants to improve his/her understanding of health economics.
EFPIAFrançois Bouvy, Executive Director Economic and Social Affairs - Belgium - October 2019 (face-to-face course)
Lieven was excellent in teaching us in this interactive session. Appreciated learning about QALYs, Markov model, sensitivity analysis, and Guidelines for Health Economic Evaluations in detail.
Vertex PharmaceuticalsAmit Shah, International Communications - United Kingdom - June 2019 (face-to-face course)
Prof. Lieven Annemans is an excellent speaker and delivers a very clear and interactive course on Health Economics. I highly valued the combination of theory & practice.
BayerInge Pool, Regulatory Affairs Manager - The Netherlands - June 2019 (face-to-face course)
Excellent program. Very clear and simple explanation of a complex topic. Lieven creates an open environment for any question and the workshops offer an immediate possibility to practice what you’ve learned.
CelgeneMartina Jerabkova, Pricing & Market Access Sr. Manager - Switzerland - June 2019 (face-to-face course)
Thank you Prof. Annemans for an excellent course on Health Economics. Thoroughly enjoyed learning in a very relaxing environment and sharing experiences with fellow colleagues.
LundbeckMayura Deshpande, Senior Medical Manager - United Kingdom - June 2019 (face-to-face course)
Thank you for the possibility to hear such an impressive speaker in such nice surroundings and for organising the whole course.
Fresenius Medical CareAndrea Gürlichová, Product Manager - Czech Republic - March 2019 (face-to-face course)
The course gives you excellent insight in the topic of HE research, delivered by a great speaker!
Modra PharmaceuticalsEric van der Putten, CEO - The Netherlands - March 2019 (face-to-face course)
By attending, you will understand the Health Economic perspective, brought in a simple but valuable and applicable way in every day practice.
SanofiMirela Horvat Kiš, Public Affairs and Market Access Country Head - Croatia - March 2019 (face-to-face course)
Great course! In only 2 days, participants are up to speed with basic HE principles and models.
Boehringer IngelheimNina Brkuljan, EU Policy Associate - Belgium - March 2019 (face-to-face course)
Excellent well-paced course that gives you the language and questioning skills of health economic assessments.
PfizerRachel Russell, Director Health Economics & Outcomes Research Team Leader - United Kingdom - March 2019 (face-to-face course)
I appreciated the expert knowledge of the speaker!
JanssenVivian Roth, Junior Product Manager - Germany - March 2019 (face-to-face course)
Thank you for a well-structured and organised program.
Abbott Vascular InternationalAnn Snoeijs, Education Manager EMEA - Belgium - December 2018 (face-to-face course)
By attending this course, you get very clear insights into how the health care decision making process is managed. Lieven Annemans has great presentation skills, real-life examples are brought in a clear way with humour.
Gilead SciencesMarijn Nivelle, Finance Manager - Belgium - December 2018 (face-to-face course)
Professor Annemans is a great expert and excellent teacher who enjoys sharing his knowledge and challenging his students.
SanofiJeroen Van Wijngaarden, Head Public Affairs - The Netherlands - October 2018 (face-to-face course)
Nice course, well organised and nicely delivered.
EisaiShaeed Chowdhury, Medical Director Northern Europe - United Kingdom - October 2018 (face-to-face course)
A very pragmatic and well paced de-mystification of the 'Dark Arts' of Health Economics, providing a good balance of why and how, + some clear tools and techniques to apply.
SanofiFaye Dack, Head of Value and Access and New Product Planning - United Kingdom - September 2018 (face-to-face course)
One of the best courses I've attended this decade.
RocheFrank Sima, Business Development & Market Access Manager - Austria - September 2018 (face-to-face course)
If you work in a Pharma company, you need to learn about this topic, otherwise you are not ready to cross-function.
AstraZenecaMohamed Aseed, Sr. Clinical Research Manager - United Arab Emirates - September 2018 (face-to-face course)
Very useful training to get a good sense of HE modelling and strategy. I feel more confident to read HE papers and challenge my HEOR colleagues!
LundbeckAlice Rouleau, Senior Epidemiology Research Manager - France - March 2018 (face-to-face course)
Prof. Annemans is highly professional with a high level of expertise. I really appreciated the examples from the trainer's experience, making the information much easier to understand. I highly recommend this course!
AbbVieAlina Nistor, Affiliate Research Manager - Romania - March 2018 (face-to-face course)
Excellent course - Very well structured with an excellent presenter who makes the complex subject of Health Economics engaging and interesting. I am now much better equipped to support health economic submissions within my own organisation.
EisaiAlly Hughes, EMEA Brand and Strategic Alliance Director - United Kingdom - March 2018 (face-to-face course)
Concise, clear, lively and includes all needed elements for understanding the health economics basics and more.
UCBCesar Libanati, Head of Medical External Affairs - Belgium - March 2018 (face-to-face course)
Highly recommended course for anyone who wants to understand HE basics with a very skilled instructor. I feel much more comfortable to start applying the theory into practice.
Philips VolcanoDavid Galliaerdt, Sr Clinical Development Manager - Belgium - March 2018 (face-to-face course)
Two cost-effective days!
GSK VaccinesGéraldine Verplancke, Project Manager, Medical & Health Outcomes - Vaccines EUROPE - Belgium - March 2018 (face-to-face course)
This course has been a fantastic overview to Health Economics and already has helped to understand previous comments made by colleagues at work. Prof. Annemans is very engaging and knowledgeable, giving very useful examples to help understand.
AstellasMary Coombs, Senior Manager, Pricing and Contracting - United Kingdom - March 2018 (face-to-face course)
Excellent course, well-delivered, great content, interesting discussions, lovely attendees, fantastic and entertaining speaker/course leader.
AstellasShirley Radforth, Director Pricing and Contracting - United Kingdom - March 2018 (face-to-face course)
Excellent course that highlights the importance of health economics in an engaging and very focused educational way.
FerringPhilip Li, Medical Scientist - Switzerland - December 2017 (face-to-face course)
I would highly recommend this course for anyone who is not a health economist but who deals with the Market Access function in his or her role. Perfect way to understand a very complex discipline in two days. Style of teaching is light and fun, while quality is thorough.
LEO PharmaVeronica Harsono, Pricing and Market Access Manager - Denmark - December 2017 (face-to-face course)
Demystifying the HE 'buzzwords' such as 'Quality of life' or 'QALY' or 'unmet medical need': this is how I would call this course. Jokes aside, I was impressed by the breadth of content that can be covered (in a non-technical language) in 2 days.
TakedaCarmen Cucul, EUCAN Business Partner Customer Strategy and Solutions - Switzerland - October 2017 (face-to-face course)
This course provided me with an important view on Health Economics applied to pharma business. It will significantly leverage my discussions with internal CFTs (Market Access, Medical Affairs, and Pricing).
Fresenius Medical CareIvo dos Reis Moreira, International Senior Therapy Manager - Germany - October 2017 (face-to-face course)
I enjoyed the pragmatic approach to assessing Health Economics studies and the steps provided to developing Health Economics approaches. Thanks!
TakedaMarek Rombel, Global Brand Leader - Switzerland - October 2017 (face-to-face course)
This is a very interesting course from which you will understand all the fundamentals of HE, modelling, and how to create models that are more appealing for the Payer to look at.
GileadEhab Hanna, Regional Market Access Manager - United Arab Emirates - June 2017 (face-to-face course)
For a complete beginner to Health Economics I found the course to be excellent and very informative. I'm very excited by my new knowledge and the added value I can bring to my role with it.
Boehringer IngelheimHumphrey Grimmett, Business Head, Pets (Vet) - United Kingdom - June 2017 (face-to-face course)
Really good insights into HE, very clear and easy to understand.
Novo NordiskZhanna Dyussenbina, Project Manager - Kazakhstan - June 2017 (face-to-face course)
This course is an eye-opener and after 2 days I realize how much I have progressed on the subject. I feel much more confident and look forward to tackling future challenges with this new knowledge-base.
JV NovarkaDominique Eggermont, Medical Director - Ukraine - June 2017 (face-to-face course)
Lieven Annemans is a thought leader/excellent tutor who taught a non-Health Economist a foundation and a few tricks in 2 days. This is a course with a massive incremental impact.
GlaxoSmithKlineAndrew Thomlinson, Senior Marketing Manager - Belgium - March 2017 (face-to-face course)
Time well spent, perfect combination of education complemented with real life examples presented in a refreshing way.
Boehringer IngelheimArne Froemder, International Project Leader - Germany - March 2017 (face-to-face course)
This course meets expectations – a summarized introduction variated with exercises to implement the learnings. Thanks to this course I will read HE articles completely different!
Vifor PharmaVeronique De Valck, Business Development Manager - Belgium - March 2017 (face-to-face course)
Fantastic course, much appreciated. Excellent balance between duration and value.
ShireDidier Weerts, Business Partner International Leadership - Switzerland - December 2016 (face-to-face course)
I followed this course as I was seeking a HE basis to support me in my regulatory expertise. HE becomes more and more important at very early phase development. This HE course will help me to think cross-disciplinary about early problems and understand the position of other departments better.Isabelle van der Dussen de Kestergat, Regulatory Affairs Professional - Belgium - December 2016 (face-to-face course)
I learned a lot of practical information to better understand HEOR and how it can be applied in new clinical development programs as well as for marketed products. Lieven Annemans is a great instructor and extremely informative. I now feel much more confident to have advanced discussions with the market access team.
Novo NordiskMark Bryant, Senior Global Marketing Director - Switzerland - December 2016 (face-to-face course)
Useful course with many real-life examples and practical recommendations. Gives really good insight into health economics in a clear and easy to understand way.
Accord HealthcareOlga Diachenko, Market Access Manager Europe - Czech Republic - December 2016 (face-to-face course)
An excellent introduction into the topic of Health Economics, helping to bring HE considerations onto the table during cross-functional discussions.
Nutricia Advanced Medical NutritionTomasz Rudka, Medical Affairs Manager - Belgium - December 2016 (face-to-face course)
While Lieven is a true health economics expert, he is also capable of explaining this specialized topic in simple wordings - I don’t feel like a dummy anymore!
ShireJoy Müller, Medical Affairs Manager - Belgium - September 2016 (face-to-face course)
Well spent time and money to get the necessary information at hand.
Boehringer IngelheimJürgen Reess, Head of Corp. Division International Project Management - Germany - September 2016 (face-to-face course)
Lieven is an excellent teacher, both engaging and energetic. The course content is easy to understand and the balance between lectures and workshops works very well. I highly recommend it.
AllerganRishi Rattan, Director, International Market Access - Ophthalmology - United Kingdom - September 2016 (face-to-face course)
This course was very interesting and very effective for me to learn the basics of health economic principles and models. It was very well organized and Prof. Lieven Annemans is a key element for the success of this course.
ChiesiTiziana Magni, Global Pricing & Market Access Jr Specialist - Italy - September 2016 (face-to-face course)
Health economics can be a scary topic. Prof. Annemans carefully and thoughtfully takes you through the subject with good humor and excellent examples. A very worthwhile investment!
AllerganJeremy Carr, Reimbursement & Market Access Manager - United Kingdom - June 2016 (face-to-face course)
This training is a must-have eye-opener for anyone in the industry who does not directly deal with reimbursement of medicines. Lieven Annemans gives a solid and balanced view on this important shift in healthcare economics, impeccably supported by the C.E.L.forpharma team. Thanks!
AbbVieLaurence Leclercq, Government Affairs Manager - Belgium - June 2016 (face-to-face course)
This course provided me a kind of missing link in the (re-)thinking of the market access procedure of a new product from a very didactic and dynamic point of view.
LillyPatrick Debbaut, Brand Manager - Belgium - June 2016 (face-to-face course)
Excellent summary of a complex area, delivered by a true expert. I would highly recommend this course!
NovartisRuby Saharan, Senior Medical Advisor - United Kingdom - June 2016 (face-to-face course)
Excellent and highly recommendable course. A gentle but nevertheless deep dive into Health Economics for a scientist like me, working in a Medical department. Lieven has great expertise on the matter and as importantly, has the capacity to pass on information clearly and respond to questions and doubts. Good atmosphere, interactive session. I highly recommend this course!
AstraZenecaDr. Quinten Remijsen, Senior Medical Science Liaison - Belgium - April 2016 (face-to-face course)
Lieven Annemans is a very good speaker. He was able to explain health economics in an easy way.
UCBLaurene Viviani, Manager Early Products - Belgium - April 2016 (face-to-face course)
Interesting introduction into health economics with a great balance of “real” examples and theory. Thanks.
UCBKristel Santens, Patient Value Mission - Belgium - January 2016 (face-to-face course)
Excellent course to expand your knowledge of health economics - with a top speaker!
ActelionSophie Vandervennet, Medical Science Liaison - Affiliate Drug Safety Officer - Belgium - January 2016 (face-to-face course)
Very well organised training with a highly recommendable professor. Useful examples, easy to understand, and will give a new perspective to my everyday work in the future. Highly recommend the course!
PfizerUna Ljubicic, Sr. Commercial & Field Force Manager GEP - Serbia - January 2016 (face-to-face course)
In our consideration to balance supply chain (value chain) environmental impacts with health care and societal benefits/impacts, this course provided a good understanding of health economics principles and methods.
JanssenBert Heirman, Senior Principal Product Stewardship Compliance - Belgium - December 2015 (face-to-face course)
The ideal course to get clarity on the complexity of Health Economics models!
AblynxLies Vanneste, Sr. Business Analyst - Belgium - December 2015 (face-to-face course)
Lieven Annemans made the content very interesting and accessible to the delegates who come from varied backgrounds. I would highly recommend!
NovartisBridget Cunningham, Drug Regulatory Affairs Advisor - Ireland - September 2015 (face-to-face course)
This course provided a great overview of the relevance and reasons for HE assessments. Lieven Annemans presented different approaches to justify the product value and provided explanations of key terminologies, in addition to receiving guidance to improve your understanding of the external HE publications.
BayerFlorian Noeske, Market Access Manager - Singapore - September 2015 (face-to-face course)
Great lessons and a very interactive format. Lieven has sound expertise!
Boehringer IngelheimHans-Jürgen Woerle, Vice President Therapeutic Area Medicine Metabolism - Germany - September 2015 (face-to-face course)
This course provides you with the knowledge and opportunity to look at reimbursement dossiers from a payer’s perspective.
GenzymeJan Rijkschroeff, Market Access Manager - The Netherlands - September 2015 (face-to-face course)
Health economics was never simple and easy to understand until I attended this course with Lieven Annemans! Fantastic job!
Gilead SciencesJanine Gaiha, Medical Manager/Scientist - Switzerland - September 2015 (face-to-face course)
This course is for everyone who used to be mystified by health economics. Lieven Annemans is great at de-mystifying a complex subject. His course is complete and detailed, yet never too complicated or boring. He is a great teacher, able to captivate the attention and deliver home the key messages.
SanofiAnja Laporte, Medical Manager - Belgium - June 2015 (face-to-face course)
If anyone wants to get a good background on Health Economics, or just better understanding of this topic, Prof. Lieven Annemans is the right teacher. He presents a unique mixture of great professional knowledge, passion, industry experience and a sense of humor. During this 2-day course I received a lot information on Health Economics to digest and to return to in the future. Well-structured and perfectly delivered. Thank you. And a big thank you to C.E.L.forpharma for making this course happen and for the excellent organization.
NovartisSlawomir Lazarewicz, Senior Director Global Medical Information - Switzerland - June 2015 (face-to-face course)
This course was exactly what I missed from my professional experience as a marketeer. Now the picture is much clearer, thank you!
JanssenÁgnes Várkonyi, Group Therapeutic Area Director - Hungary - February 2015 (face-to-face course)
I got very helpful insights and a good understanding of how health economic principles work. I would highly recommend attending this course with this excellent presenter if you want to brush up your understanding of 'Health Economics'.
BaxterClaudia Lentner-Böhm, Head of Health Economics Hospital Care DACH - Germany - February 2015 (face-to-face course)
Prof. Lieven Annemans is highly capable of explaining health economics in a very clear way, comprehensive for people with no experience in health economics. In two days the participant is introduced into this science.
CSL BehringErika Maris, Medical Advisor - Belgium - February 2015 (face-to-face course)
This course answered all my questions I had on this topic!
GileadHugo Vanhecke, Product Manager - Belgium - February 2015 (face-to-face course)
Very good course, well organised, and executed by an excellent expert with a high level of knowledge and great presentation skills. Summarised: this course is good value for money, even though not cheap, this is clearly a cost-effective course!
GrünenthalKai Strohtmann, Senior Director Commercial Assessment - Germany - February 2015 (face-to-face course)
Very good training with a talented professor. I recommend this course to all people who want to learn more about HEOR.
PfizerBaptiste Dupuy, EU Brand Manager - France - December 2014 (face-to-face course)
Very helpful for non-health-economists. Steep learning curve in 2 days!
BayerFalko Heinze, Global Brand Manager - Germany - December 2014 (face-to-face course)
One of the best trainings I've ever attended! Lieven Annemans delivers and trains heavy and complex theories in an easy to follow and entertaining way. Great course!
BayerFolma Maren Kiser, Brand Manager - Germany - December 2014 (face-to-face course)
Great training, very well organised, balanced and adapted to the audience. Clearly presented and very helpful to current pharma employees!
Eli LillyMilena Randjelovic, PRA and Sales Manager - Serbia - December 2014 (face-to-face course)
A great course which gives a great overview of HE in a clean & understandable way. Highly recommended for all people involved in healthcare. I hope to be able to convince my colleagues to join in! Thank you very much for a great learning experience.
GlaxoSmithKline VaccinesRik Quaghebeur, Senior Manager Tender, Pricing & Allocations - Belgium - December 2014 (face-to-face course)
This course is well-designed and structured for academic participants who wish to get a concise intro to Health Economics.
University of BergenSumathi Subramaniam, Senior Advisor for Externally Financed Research, Division of Research Administration - Norway - December 2014 (face-to-face course)
Excellent introduction to pharmacoeconomics with a very knowledgeable expert. Enlightening & entertaining!
BayerGunnar Schroefel, Global Advocacy Lead - Germany - May 2014 (face-to-face course)
A very nice introductory course on HE. Dr. Annemans is very passionate about the topic and provides very practical examples.